Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
about
Plug-and-Play Pairing via Defined Divalent StreptavidinsStructure-based design and synthesis of a bivalent iminobiotin analog showing strong affinity toward a low immunogenic streptavidin mutantStructure-based design of a streptavidin mutant specific for an artificial biotin analogueTwo-Step Delivery: Exploiting the Partition Coefficient Concept to Increase Intratumoral Paclitaxel Concentrations In vivo Using Responsive Nanoparticles.A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.The road to purified hematopoietic stem cell transplants is paved with antibodies.Radioimmunotherapy for hematopoietic cell transplantation.Streptavidin-biotin technology: improvements and innovations in chemical and biological applications.Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers.Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.Advances and application of radioimmunotherapy in non-Hodgkin lymphoma.An innovative pre-targeting strategy for tumor cell specific imaging and therapy.CD38 bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B cell malignancies.
P2860
Q27680010-F851B7C3-24F7-4BCE-BD04-3DB90D40815FQ27697299-6CAF9C3C-F7D8-4957-A865-4B6B6751FC35Q27697883-37B1F4CC-AE6D-42D0-80B1-A393F01A6FD0Q36438435-E66F6C25-10AE-43FD-84F0-CF70011F4968Q37675882-F05BDDB1-C884-420A-9FDD-6279EEBE15A5Q38039703-FF546C74-B24D-4ACC-90BE-F2B4C501739AQ38096058-7A32EE7D-41DB-483C-869A-FA1307558D96Q38140695-FCD3DACF-21DC-41A6-AA8F-43C7203F3C69Q38799356-9A8C2715-EE93-474B-9D77-14FA273163C2Q39129504-4A22828E-B44E-4AA9-97B1-A1376946A220Q39591787-49B5CF96-3C2A-4601-87CC-DF2A346313D2Q41471065-3FDEF70D-8651-4EB2-A55B-58013A13F06CQ47329597-DD8BBDF6-EFF5-49F7-A414-C24D5FF9D1F4
P2860
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@ast
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@en
type
label
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@ast
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@en
prefLabel
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@ast
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@en
P2093
P2860
P1476
Pretargeted radioimmunotherapy ...... tment of non-hodgkin lymphoma.
@en
P2093
Aimee L Kenoyer
Amanda Axtman
D Scott Wilbur
Damian J Green
Donald K Hamlin
Franz Buchegger
Jaideep Shenoi
John M Pagel
Mark Hylarides
Nural Orgun
P2860
P304
P356
10.1158/1078-0432.CCR-11-1204
P407
P577
2011-10-05T00:00:00Z